Strong Revenue Growth
Revenues of $58.4 million, up 21% year-over-year, driven by the MindBody GLP1 system. U.S. revenues grew 31%.
Improved Profitability
Adjusted EBITDA increased 27% year-over-year to $6.4 million, with adjusted EBITDA margin improving 50 basis points to 11%.
Successful Product Launches
International expansion of MindBody system began, showing momentum in markets like Japan, Australia, New Zealand, Mexico, the UK, Europe, and Thailand.
Active Accounts and Subscriptions Growth
Active accounts increased by 17% in the Americas, with a 13% increase in independent consultants and a 19% increase in customers. Subscriptions showed strong growth, with global active templates increasing by over 10,000.
Clinical Study Results
New clinical study revealed that MindBody GLP1 system increased GLP1 levels by over 200% on average.